A detailed history of Janus Henderson Group PLC transactions in Pfizer Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 527,829 shares of PFE stock, worth $14.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
527,829
Previous 576,175 8.39%
Holding current value
$14.5 Million
Previous $16 Million 7.63%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $1.22 Million - $1.43 Million
-48,346 Reduced 8.39%
527,829 $14.8 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $5.29 Million - $6.07 Million
-204,315 Reduced 26.18%
576,175 $16 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $6.05 Million - $7.86 Million
231,644 Added 42.21%
780,490 $22.5 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $83.2 Million - $97.2 Million
-2,591,411 Reduced 82.52%
548,846 $18.2 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $15.9 Million - $18.3 Million
-438,915 Reduced 12.26%
3,140,257 $115 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $2.16 Million - $2.81 Million
54,860 Added 1.56%
3,579,172 $146 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $5.18 Million - $6.76 Million
-124,057 Reduced 3.4%
3,524,312 $181 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $13.8 Million - $16.8 Million
315,312 Added 9.46%
3,648,369 $160 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $53 Million - $62.8 Million
-1,138,805 Reduced 25.47%
3,333,057 $175 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $160 Million - $198 Million
3,488,305 Added 354.66%
4,471,862 $232 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $10.1 Million - $15 Million
244,483 Added 33.08%
983,557 $58.1 Million
Q3 2021

Nov 16, 2021

SELL
$39.25 - $50.42 $8.6 Million - $11.1 Million
-219,202 Reduced 22.87%
739,074 $31.8 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $118 Million - $134 Million
-3,286,278 Reduced 77.42%
958,276 $37.5 Million
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $11.3 Million - $12.7 Million
-336,381 Reduced 7.34%
4,244,554 $154 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $15.9 Million - $20.2 Million
-475,164 Reduced 9.4%
4,580,935 $169 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $14.7 Million - $17.3 Million
-464,249 Reduced 8.41%
5,056,099 $186 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $13.1 Million - $15.9 Million
-433,873 Reduced 7.29%
5,520,348 $180 Million
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $52.7 Million - $75.4 Million
-1,951,370 Reduced 24.68%
5,954,221 $194 Million
Q4 2019

Feb 18, 2020

SELL
$32.92 - $37.36 $41 Million - $46.6 Million
-1,246,496 Reduced 13.62%
7,905,591 $310 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $23.5 Million - $30.5 Million
-723,246 Reduced 7.32%
9,152,087 $312 Million
Q2 2019

Jul 31, 2019

SELL
$36.98 - $41.52 $49.1 Million - $55.1 Million
-1,326,946 Reduced 11.85%
9,875,333 $428 Million
Q1 2019

Apr 30, 2019

BUY
$37.5 - $41.2 $78.5 Million - $86.2 Million
2,092,272 Added 22.97%
11,202,279 $476 Million
Q4 2018

Feb 06, 2019

SELL
$38.47 - $43.86 $88.1 Million - $100 Million
-2,290,532 Reduced 20.09%
9,110,007 $398 Million
Q3 2018

Nov 09, 2018

SELL
$34.47 - $41.81 $13.7 Million - $16.6 Million
-397,048 Reduced 3.37%
11,400,539 $502 Million
Q2 2018

Aug 10, 2018

SELL
$32.98 - $35.16 $3.56 Million - $3.8 Million
-108,010 Reduced 0.91%
11,797,587 $428 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $6.1 Million - $7.08 Million
191,128 Added 1.63%
11,905,597 $423 Million
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $20.4 Million - $21.6 Million
612,756 Added 5.52%
11,714,469 $425 Million
Q3 2017

Nov 14, 2017

SELL
$31.0 - $34.15 $64.3 Million - $70.8 Million
-2,073,474 Reduced 15.74%
11,101,713 $0
Q2 2017

Aug 17, 2017

BUY
N/A
13,175,187
13,175,187 $443 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.